Cooperative Agreement 90MPPG0005

The U.S. Department of Health and Human Services Administration for Community Living awarded a $2,320,186 Cooperative Agreement to the Ohio Department of Insurance to support the Ohio Senior Health Insurance Information Program (OSHIIP) under the State Health Insurance Assistance Program (CFDA 93.324). The Cooperative Agreement, with a period of performance from April 1, 2025, through March 31, 2030, will enable OSHIIP to provide comprehensive counseling, education, and assistance to...

The Ohio Department of Mental Health and Addiction Services (OhioMHAS) was awarded a $5,796,760.00 Block Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Community Mental Health Services program (CFDA 93.958). This 2-year grant, with a period of performance from September 30, 2023 to September 29, 2025, will enable OhioMHAS to deliver comprehensive community-based mental health services to adults with serious mental illness and children...

The Supreme Court of Ohio received a $962,064.75 cooperative agreement award from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program. The award period is from October 1, 2017 through July 31, 2022 to enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through the state's centralized prescription drug monitoring database, as outlined...

The U.S. Small Business Administration's Office of International Trade awarded a $300,000 Project Grant under the State Trade Expansion Program (CFDA 59.061) to the Ohio Department of Development (ODSA) on September 30, 2024. This two-year grant supports ODSA's efforts to increase export activities and expand the international market presence of eligible small businesses in Ohio. Key grant-funded services include export training, trade missions, international marketing assistance, trade show...

This $382,557 federal Formula Grant award from the U.S. Department of Health and Human Services Administration for Community Living (CFDA 93.071 - Medicare Enrollment Assistance Program) provides funding to the Ohio Department of Aging for the Medicare Improvements for Patients and Providers Act (MIPPA) program. The grant supports outreach, education, and application assistance for Medicare beneficiaries to improve their access to preventive, wellness, and limited income benefits. The Ohio...

The Ohio State Board of Pharmacy (OSBP) received a $1,364,055 federal Project Grant award from the Department of Justice's Bureau of Justice Assistance through the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The award will fund initiatives to enhance and expand the capabilities of Ohio's prescription drug monitoring program, known as the Ohio Automated Rx Reporting System (OARRS). Key objectives include improving the accuracy, completeness, and utilization of OARRS data...

The Ohio Department of Health was awarded a $6 million project grant from the Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program to implement evidence-based substance use disorder treatment and harm reduction services in six counties. The three-year award will support expanding harm reduction activities and education targeting Black and Hispanic populations in high-risk areas; improving access to medication-assisted...

The U.S. Department of Health and Human Services Administration for Community Living awarded a $638,014 Formula Grant to the Ohio Department of Aging under the Medicare Enrollment Assistance Program (CFDA 93.071). This federal grant program provides funding to support outreach, education, and application assistance for Medicare beneficiaries, with a focus on helping eligible individuals access preventive, wellness, and limited income benefits. The Ohio Department of Aging will use the grant...

The federal Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR (CFDA 93.788) program, provides $400,907,000 to the Ohio Department of Mental Health to address the opioid and stimulant crisis in Ohio. The award will continue the state's efforts to flatten opioid and drug poisoning death rates, increase access to harm reduction, focus on peer recovery supports, expand evidence-based practices, and increase upstream...

The federal Formula Grant award of $1,529,227.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). The grant funding supports Disability Rights Ohio, the designated Protection and Advocacy (P&A) system for the state of Ohio, to deliver comprehensive legal advocacy and rights protection services for individuals with mental illness. Key services include...